Pluri (NASDAQ:PLUR) Posts Quarterly Earnings Results

Pluri (NASDAQ:PLUR) issued its earnings results on Tuesday. The company reported ($0.53) EPS for the quarter, Zacks reports. Pluri had a negative return on equity of 917.18% and a negative net margin of 4,184.28%.

Pluri Trading Up 0.7 %

Shares of PLUR stock traded up $0.03 during mid-day trading on Tuesday, reaching $4.33. The stock had a trading volume of 4,142 shares, compared to its average volume of 13,152. The firm has a market capitalization of $24.07 million, a PE ratio of -0.72 and a beta of 1.67. The stock’s 50-day moving average price is $4.53 and its two-hundred day moving average price is $4.99. The company has a current ratio of 5.90, a quick ratio of 5.90 and a debt-to-equity ratio of 4.44. Pluri has a 52-week low of $4.07 and a 52-week high of $8.48.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.